Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs SKALE (SKL) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs SKALE — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while SKALE trades at Rp60.4 (market cap Rp373,81M, Rp59,13M 24h volume). The key difference: SKALE is far larger — about 2.8× Enzyme's market cap, and SKALE's supply is capped (6,2B / 7B SKL (89%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and SKALE for 19 Days on average.

MLNSKL
Market Cap
Rp134,13MRp373,81M
Volume (24h)
Rp104,56MRp59,13M
Circulating Supply
3,3M MLN6,2B / 7B SKL (89%)
Typical Hold Time
29 Days19 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

SKALE

SKALE is trading at Rp60.622 with a market cap of Rp374.67M, showing a bearish technical signal driven by moving averages, while oscillators are neutral. The token is near its support at Rp60, with RSI levels indicating potential oversold conditions. No major protocol updates or ecosystem news are currently available.

The overall outlook is cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include potential rebounds from oversold levels, but risks involve low liquidity, high volatility, and the absence of recent positive developments. Investors should monitor for any network activity or exchange updates.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

SKL
59% Buy41% Sell
Avg holding period · 19 Days

Top news

Latest headlines on both assets

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About SKALE

SKALE is a blockchain network built to support decentralized applications (dApps) with zero gas fees, high speed, and unlimited scalability. It consists of EVM-compatible Layer 1 blockchains, called SKALE Chains, which can be dedicated to a single dApp or shared among multiple dApps. These modular chains provide pooled security, dynamic scaling, and flexible resource allocation, making dApp deployment more efficient and user-friendly.

Read more on SKL